Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Signs Agreement For Phase 2 Study In Kidney Transplantation

June 13 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * SIGNS AGREEMENT WITH CRO SUPPLIER FOR PHASE 2 STUDY IN
KIDNEY
TRANSPLANTATION AND ADDS SUPPLIER OF DRUG SUBSTANCE
    * EXPECTS TO INITIATE THE FIRST TRANSPLANT CLINICS IN EUROPE
IN
LATE Q3 2022
    * EXPECTS DELIVERY OF DRUG SUBSTANCE FOR THE STUDY TO OCCUR
IN Q4
2022

Source text for Eikon:  ID:nGNEbyj21b 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news